While its often used to describe a number of different features, its generally a category in anti-aging
In the SELECT trial, in patients with obesity (BMI 27 kg/m 2 ) and established cardiovascular disease but not diabetes, semaglutide resulted in a 20% reduction in major adverse cardiovascular events (MACE), while in the STEP-HFpEF trial, among patients with obesity (BMI 30 kg/m 2 and heart failure with preserved ejection fraction but not diabetes), semaglutide improved heart failure symptoms and physical function, explained the study authors
Clinically provenweight loss treatments Prescription medications, personalized to your needs, delivered to your door
Weight loss from semaglutide persists as long as one remains on the medication
When a program advertises a single low headline number, it is worth asking which bucket that figure represents and what the combined out-the-door total looks like